AbbVie Inc. $ABBV Stake Lowered by Albion Financial Group UT

robot
Abstract generation in progress

Albion Financial Group UT significantly reduced its stake in AbbVie Inc. by 47.9% in Q4, selling 22,007 shares. Despite AbbVie beating Q4 earnings and revenue estimates, the stock was impacted by a trimmed Q1 and full-year outlook due to a $744M R&D charge. The company announced a quarterly dividend of $1.73, while institutional ownership stands at approximately 70% with analysts maintaining a “Moderate Buy” rating and a target price of $253.15.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin